The R&D budget for Health and Medical Sciences in Japan as a percentage of GDP is forecasted to grow steadily from 2024 to 2028, starting at 0.049% and increasing incrementally each year to reach 0.054% by 2028. This projected annual increase indicates Japan's commitment to enhancing research in this vital sector. The year-on-year growth rates are modest, reflecting a stable investment approach. The compound annual growth rate over the five-year period suggests consistent expansion slightly above the inflation rate.
Future trends to watch for include Japan's strategic focus on innovation in healthcare technology, aging population challenges, and potential collaborations between public and private sectors to further boost investment in medical science R&D.
